What if a single policy change could jeopardize decades of progress in safeguarding children from a silent, deadly virus, and what would be the consequences of such a shift? The debate over delaying the hepatitis B vaccine from birth to age 4 has erupted into a heated controversy, pitting public
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a keen understanding of technological innovation in the industry. Today, we’re diving into the exciting world of precision oncology and drug discovery,
Imagine a world where millions of lives are lost each year to preventable conditions like heart disease, cancer, and diabetes, yet the momentum to combat these killers slows to a troubling crawl, leaving health systems and economies grappling with the consequences. In 2019, non-communicable
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technology and innovation in the industry. Today, we’re diving into a pressing topic: the potential connection between processed red
In an era where access to reliable health information can make a significant difference in public safety, South Korea's Ministry of Food and Drug Safety is taking bold steps to enhance its digital resources for medical devices. With millions of people relying on accurate data to make informed
Brazil is emerging as a formidable force in the global clinical research arena, thanks to the recent enactment of Law 14.784/14, a pivotal regulation designed to overhaul the nation’s approach to clinical trials. Spearheaded by ANVISA, Brazil’s health regulatory agency, this legislation targets
